Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease.

Item

http://www.wikidata.org/entity/Q55404441

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease.

@en

Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease.

@nl

type

Item

label

Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease.

@en

Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease.

@nl

prefLabel

Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease.

@en

Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease.

@nl

P1476

Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease.

@en

P2093

A Granata

http://www.w3.org/2001/XMLSchema#string

P Lentini

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

End-stage renal disease in the United States: an update from the United States Renal Data System.

A novel approach to control hyperglycemia in type 2 diabetes: sodium glucose co-transport (SGLT) inhibitors: systematic review and meta-analysis of randomized trials.

The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.

Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area.

Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes.

P304

317507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1155/2015/317507

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

P5008

ScienceSource

P577

2015-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273493438

http://www.w3.org/2001/XMLSchema#string

P698

25785281

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

glucose

chronic kidney disease

P932

4345065

http://www.w3.org/2001/XMLSchema#string